Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189319
Status:
COMPLETED
Last Update Posted:
2022-02-07
First Post:
2005-09-13
Brief Title:
To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation
Sponsor:
MEDA Pharma GmbH Co KG
Organization:
Viatris Inc
Organization Data
Organization:
Viatris Inc
Class:
INDUSTRY
Study ID:
1478-FLEC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MEDA Pharma GmbH Co KG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None